Figure 1From: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malariaStudy design. (*) Two patients did not undergo a parasite evaluation between D3 and D14 (patients withdrawn from the study). (**) 11 patients presented major deviations and five patients did not complete the study. Five patients, three in the single-intake group and two in the two-intake group, did not undergo an evaluation on D14. These patients moved out of the area covered by the investigating centre before the end of the study.Back to article page